PTGX position history
The shares of Protagonist Therapeutics (PTGX) that Duquesne Family Office LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q3: 159,700 shares, $11M, 0.26% of portfolio, New
- 2025 Q4: 159,700 shares, $14M, 0.31% of portfolio
- 2026 Q1: 159,700 shares, $17M, 0.50% of portfolio
- 2026 Q2: 208,900 shares, $26M, 0.49% of portfolio, Add +30.8%
- 2026 Q3: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|